SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas Phase 3 melanoma-vaccine data showed a reduced risk of recurrence or death when added to Keytruda, but the results fell short of elevated expectations after a sharp run-up, fueling a steep sell-the-news selloff. Traders are divided over whether the clinical benefit makes the decline an overreaction or whether valuation and profit-taking leave room for further pressure.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet shares are under pressure ahead of earnings, with traders focused on whether AI and data-center spending will translate into returns and how management will address capital expenditure and cash-flow concerns. Some see the pullback as a buying opportunity given the companys search, cloud, and AI businesses, while others expect further weakness amid broader tech selling and a deteriorating chart.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is drawing attention as crude rises amid Iran-related tensions, Strait of Hormuz shipping risks and Houthi threats to regional energy infrastructure, stoking fears of supply disruptions. Traders disagree on whether the rally reflects lasting scarcity or an overstated geopolitical risk premium, with diplomacy and reports of recovering oil flows cited as reasons for caution.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. It operates through the Hard Disk Drives (HDD) segment. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Western Digitals strong quarterly results and upbeat guidance failed to prevent a sharp selloff amid broader pressure on AI-linked storage and semiconductor shares. Traders are split between viewing the decline as a risk-off, sell-the-news move despite robust storage demand and worrying that strong pricing and margins may mark a cyclical peak.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, and Defense. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

A sharp pullback has prompted debate over whether the weakness reflects broader market and aerospace-sector pressure, higher oil and fuel costs, or profit-taking rather than a deterioration in Rolls-Royces business. Bulls are treating the decline as a buying opportunity, pointing to buybacks, raised guidance and strong long-term demand, while others warn that selling momentum could continue.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

IWM is caught in volatile small-cap trading as traders weigh rising oil and Middle East escalation against inflation and the risk of tighter Fed policy, concerns that could pressure rate-sensitive companies. The community is split between bearish views on technical weakness and hopes for a rebound or rotation into small caps; an unconfirmed U.S.Iran deal report also fueled a rally that some traders dismissed as rumor-driven.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Metas post-earnings selloff is centered on concerns that heavier AI infrastructure spending and negative free cash flow could pressure returns, with the new nonvoting share structure adding to worries about potential dilution. Traders are split between viewing the decline as a buying opportunity after strong business results and fearing that AI investment costs and financing needs outweigh the growth outlook.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

WULF is drawing attention after a sharp selloff, with traders debating whether debt, financing needs and execution risks around its AI/HPC data-center buildout are weighing on the shares. Bulls cite long-term demand for power-backed computing capacity and see the stock as oversold, while bears question whether the company can fund and deliver its expansion profitably.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavaxs IDWeek presentation on its COVID-19/flu combination vaccine is the main focus, with traders debating whether the reported immune-response results strengthen the case for a partner or whether the lack of detailed public data made the event a non-event. The share-price drop has frustrated holders, while some traders point to broader vaccine-sector weakness and Modernas moves rather than a confirmed company-specific setback.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

A sharp semiconductor selloff followed LAM Researchs warning that component supply constraints could limit chipmakers ability to meet demand, adding to concerns about AI spending and the durability of the chip rally. Traders are split between calling the drop an oversold buying opportunity near technical support and warning that bearish momentum and AI-bubble fears could bring further losses.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Do Options Traders Know Something About Harrow Stock We Don't?

Investors need to pay close attention to HROW stock based on the movements in the options market lately.

Harrow's Iheezo Cuts Eye-Injection Discomfort by More Than Half

Harrow (NASDAQ: HROW) posts positive study results for IHEEZO ophthalmic gel, significantly reducing IVT injection patient discomfort.read more...

Harrow (HROW) Reports Q2 Loss, Misses Revenue Estimates

Harrow (HROW) delivered earnings and revenue surprises of -47.83% and -0.61%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Ironwood Pharmaceuticals (IRWD) Q2 Earnings Top Estimates

Ironwood (IRWD) delivered earnings and revenue surprises of +19.23% and -5.66%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

HROW Stock Rises on Relaunch of Ophthalmology Drug Verkazia in the US

Harrow shares gain after relaunching Verkazia in the United States, aiming to improve access to an FDA-approved VKC treatment for pediatric patients.

Harrow (HROW) Reports Q1 Loss, Lags Revenue Estimates

Harrow (HROW) delivered earnings and revenue surprises of -48.24% and -12.17%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Zoetis (ZTS) Misses Q1 Earnings and Revenue Estimates

Zoetis (ZTS) delivered earnings and revenue surprises of -5.09% and -1.66%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Relay Therapeutics, Inc. (RLAY) Reports Q1 Loss, Lags Revenue Estimates

Relay Therapeutics (RLAY) delivered earnings and revenue surprises of -18.84% and -80.46%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Harrow (HROW) Projected to Post Quarterly Earnings on Monday

Harrow (NASDAQ:HROW) will be releasing its Q1 2026 earnings after the market closes on Monday, May 11. (View Earnings Report at...

Analysts Estimate Harrow (HROW) to Report a Decline in Earnings: What to Look Out for

Harrow (HROW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Branded and ImprimisRx. The Branded segment includes activities of the company’s FDA approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain branded products. The ImprimisRx segment represents activities in the company’s ophthalmology-focused pharmaceutical compounding business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow To Acquire Sedation Solutions Developer Melt Pharmaceuticals – More Details Inside

Equity

Neutral Sentiment

Harrow (HROW) announced on Friday that it has entered into an agreement to acquire privately held Melt Pharmaceuticals for an undisclosed price.While Harrow is a provider of ophthalmic disease management solutions, Melt Pharmaceuticals is focused on developing non-opioid therapies for sedation during medical procedures. Melt was spun out of Harrow in January 2019.The acquisition will <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.harrow.com/news-releases/news-release-details/harrow-acquire-melt-pharmaceuticals">include</a> Melt’s lead investigational therapy, MELT-300, a sublingually delivered formulation of a fixed dose of Midazolam (3mg) and Ketamine (50mg) designed to provide rapid, predictable sedation and analgesia without the need for intravenous administration.Shares of Harrow jumped 4% at the time of writing. On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/HROW">HROW stock</a> stayed within ‘extremely bullish’ territory over the past 24 hours, while message volume stayed at ‘high’ levels.MELT-300 was found to be statistically superior to both sublingual Midazolam alone and placebo in providing successful procedural sedation in a late-stage study. A recently completed cardiac safety study also indicated that MELT-300 did not alter normal heart rhythm, supporting the therapy’s safety profile. Harrow now plans to submit a new drug application to the U.S. Food and Drug Administration for the sedative in 2027, and is eyeing a commercial launch in the U.S. in 2028.If the FDA approves MELT-300, the company intends to discontinue the MKO Melt sedation product, marketed through its ImprimisRx subsidiary, for cataract surgeries. The company also sees potential for MELT-300 to be used in other procedures, including claustrophobia during MRIs, sedation for colonoscopies, dental procedures, gastroenterology procedures, and other interventions.The closing of the merger transaction, however, is subject to customary closing conditions, including approval by Melt shareholders, Harrow added.HROW stock is up 43% this year and by about 9% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/costco-draws-mixed-reactions-from-wall-street-despite-q4-beat-here-is-why/chDVjZGR3eX">Costco Draws Mixed Reactions From Wall Street Despite Q4 Beat: Here’s Why</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Global stock market chart and trading board - stock photo

The acquisition will include Melt’s lead investigational therapy, MELT-300, designed to provide rapid, predictable sedation and analgesia without the need for intravenous administration. 

Harrow Health Inc

BlackRock Institutional Trust Company N.A. - iShares Russell 3000 ETF

Vanguard Russell 2000 Growth ETF

Very bullish

Cautiously bullish

Cautiously bearish

Very bearish

Stocktwits sentiment on $SPY just hit its lowest level of the year. How are you feeling about the market right now?

Stocktwits

 just hit its lowest level of the year. How are you feeling about the market right now?

Current Price	$28.15
Prev Close	$28.24
Open	$27.82
Dividend Yield	0.00%
50-Day Moving Average	$34.21
Beta	1.43
Avg. Volume	563,015.37
PE Ratio	-28.16

52-Week High	$54.85
52-Week Low	$26.96
Market Capitalization	$1.06B
EPS (Annual)	-$0.1398
Price to Book	69.42
Revenue Per Employee	$730,034.85

Feed

News

Sentiment

Earnings

Fundamentals

Info

HROW Fundamentals